This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
▼
Thursday, October 6, 2016
Watch - Debrief Recording of EASL Recommendations on Treatment of Hepatitis C 2016
Watch Pr. Jean-Michel Pawlotsky review the highlights of EASL’s recommendations on treatment of Hepatitis C 2016 EASLEurope
No comments:
Post a Comment